Samsara BioCapital’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
Other funds holding STRO
KCM
Samsara BioCapital's STRO Position: Q3 2026 in Review
Samsara BioCapital held its Sutro Biopharma (STRO) position steady in Q3 2026 at 1,062,872 shares worth $17.1M. The position accounts for 1.63% of the portfolio, ranked #11.
Samsara BioCapital first reported a position in STRO in Q4 2018 and has held it in 32 quarters since. The position peaked at $38.1M in Q1 2021. 100 funds tracked by Wall St. Rank hold STRO as of Q3 2026.
- Samsara BioCapital held 1,062,872 shares of Sutro Biopharma worth $17.1M as of Q3 2026.
- Samsara BioCapital left its Sutro Biopharma share count unchanged in Q3 2026.
- Sutro Biopharma made up 1.63% of Samsara BioCapital's portfolio in Q3 2026, its #11 holding.
- Samsara BioCapital first reported a position in Sutro Biopharma in Q4 2018 and has held it in 32 quarters since.
- Samsara BioCapital's Sutro Biopharma position peaked at $38.1M in Q1 2021.
- 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2026.
Based on Samsara BioCapital's 13F filing for Q3 2026, filed 16 Nov 2026.